PEGylated SLN as a Promising Approach for Lymphatic Delivery of Gefitinib to Lung Cancer

Abstract

These results concluded that GEF-P-SLN is a promising approach to improving the therapeutic outcomes of GEF in the treatment of metastatic lung cancer.